K. Oki - 11 Aug 2023 Form 4 Insider Report for AYTU BIOPHARMA, INC (AYTU)

Role
Chief Financial Officer
Signature
/s/ Mark K. Oki
Issuer symbol
AYTU
Transactions as of
11 Aug 2023
Net transactions value
$0
Form type
4
Filing time
15 Aug 2023, 20:28:59 UTC
Previous filing
28 Nov 2022
Next filing
09 Dec 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AYTU Employee Stock Option (Right to Buy) Award $0 +13,000 $0.000000 13,000 11 Aug 2023 Common Shares 13,000 $1.73 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The options vest as follows: 1/3 on August 11, 2024, with the remaining options vesting in 24 equal monthly installments beginning September 11, 2024.